evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Older drug may help protect brains of Alzheimer's patients GLP-1 Receptor Agonists | New

Any unexpected reaction is reported through the clinics adverse-event protocol and triggers a documented response, not a generic chat reply

Primary outcome: Percentage change in body weight and the proportion of participants who lost at least 5% of baseline weight by week 68 Results: Primary outcome (% weight loss): Wegovy - 16%, Placebo - 5.7% (p 35 - 68.9% Randomized treatment groups Group 1 (374 patients): Tirzepatide titrated to the maximum tolerated dose of 10 mg or 15 mg once weekly Group 2 (376 patients): Semaglutide titrated to the maximum tolerated dose of 1.7 mg or 2.4 mg once weekly Tirzepatide was initiated at a dose of 2.5 mg once weekly, and the dose was increased by 2.5 mg every 4 weeks until a maximum tolerated dose of 10 mg or 15 mg was reached

It also contributes to better heart health and can lead to more restful sleep, helping you feel refreshed and ready to take on the day

Manufacturer Martin Dow Pharmaceuticals (Pak) Ltd Form Injection Pack size Pack of 25 Inj Prescription Relaxed may be requested MRP Rs.1,500 Common side effects Black, tarry, or bloody stools